Neuroventi Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase II Clinical Trial to Evaluate the Efficacy and Safety of NV01-A02 in Children With Autism Spectrum Disorder (NCT06951854) | Neuroventi Inc. | 2025-04-01 |
Track Neuroventi Inc. automatically
Every clearance here is in the API, with alerts when new ones post.